← The Wire
CADLNasdaq
Candel Therapeutics, Inc.
Biological Products, (No Diagnostic Substances) · DE · CIK 1841387
Developing off-the-shelf viral immunotherapies to elicit individualized, systemic anti-tumor immune responses against cancer
red 8-K · 90d
$627M
Market cap
$10.36
Last close
+5.8%
1D
+13.2%
5D
1.5M
Volume
Price · last 39 sessions+37.6%
May 4L $7.53 · H $10.36Jun 29
128
Total filings
Jun 24, 2026
Last filing
12/31
Fiscal year end
8-KShareholder VoteJun 24, 20268-KExecutive ChangeJun 16, 20268-KReg FD DisclosureMay 15, 202610-Q10-QMay 14, 20268-KResults of OperationsMay 14, 2026DEFA14ADEFA14AApr 29, 2026DEF 14ADEF 14AApr 29, 2026SC 13D/ASC 13D/AMar 18, 202610-K10-KMar 12, 20268-KResults of OperationsMar 12, 20268-KMaterial Agreement · Company UpdateFeb 23, 2026424B5424B5Feb 20, 2026424B5424B5Feb 19, 20268-KMaterial Agreement · Results of OperationsFeb 19, 20268-KReg FD DisclosureDec 5, 202510-Q10-QNov 13, 20258-KResults of OperationsNov 13, 20258-KMaterial Agreement · Results of OperationsOct 14, 20258-KMaterial AgreementAug 21, 202510-Q10-QAug 14, 20258-KResults of OperationsAug 14, 20258-KMaterial Agreement · Reg FD DisclosureJun 24, 2025424B5424B5Jun 24, 20258-KExecutive Change · Reg FD DisclosureJun 23, 20258-KShareholder VoteJun 18, 20258-KExecutive Change · Reg FD DisclosureJun 6, 20258-KReg FD Disclosure · Company UpdateMay 28, 20258-KReg FD DisclosureMay 22, 202510-Q10-QMay 13, 20258-KResults of OperationsMay 13, 2025DEFA14ADEFA14AApr 29, 2025DEF 14ADEF 14AApr 29, 20258-KReg FD DisclosureApr 23, 20258-KReg FD Disclosure · Company UpdateMar 27, 202510-K10-KMar 13, 20258-KResults of OperationsMar 13, 20258-KReg FD Disclosure · Company UpdateFeb 25, 20258-KResults of Operations · Reg FD DisclosureJan 13, 2025SC 13GSC 13GDec 17, 20248-KMaterial Agreement · Company UpdateDec 13, 2024424B5424B5Dec 13, 2024424B5424B5Dec 12, 20248-KReg FD Disclosure · Company UpdateDec 11, 202410-Q10-QNov 14, 20248-KResults of OperationsNov 14, 20248-KReg FD Disclosure · Company UpdateOct 28, 202410-Q10-QAug 13, 20248-KResults of OperationsAug 13, 20248-KShareholder VoteJun 28, 2024DEF 14ADEF 14AMay 30, 20248-KBylaw AmendmentMay 30, 2024424B5424B5May 24, 20248-KReg FD Disclosure · Company UpdateMay 23, 202410-Q10-QMay 14, 20248-KResults of OperationsMay 14, 20248-KReg FD DisclosureApr 25, 202410-K/A10-K/AApr 25, 20248-KReg FD Disclosure · Company UpdateApr 11, 20248-KReg FD Disclosure · Company UpdateApr 9, 20248-KReg FD Disclosure · Company UpdateApr 4, 202410-K10-KMar 28, 20248-KResults of OperationsMar 28, 20248-KReg FD DisclosureMar 6, 2024424B5424B5Feb 13, 20248-KReg FD Disclosure · Company UpdateFeb 13, 20248-KExecutive ChangeJan 12, 20248-KCompany UpdateJan 3, 20248-KExecutive ChangeDec 15, 20238-KReg FD DisclosureDec 12, 20238-KExit / Disposal CostsNov 28, 20238-KDelisting NoticeNov 21, 202310-Q10-QNov 9, 20238-KResults of OperationsNov 9, 20238-KReg FD Disclosure · Company UpdateNov 6, 20238-KReg FD Disclosure · Company UpdateNov 6, 20238-KReg FD DisclosureOct 18, 20238-KReg FD DisclosureSep 26, 202310-Q10-QAug 10, 20238-KResults of OperationsAug 10, 20238-KShareholder VoteJun 29, 2023
Insider Activity
In the 90 days to Feb 23, 2026: 1 insider bought $3.0M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 23, 2026 | Manning Paul BDirector | Buy | 550,458 | $5.45 | $3.0M |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance